Becton Dickinson EVP Sells $123k in Stock Under 10b5-1 Plan
BECTON DICKINSON & CO
Subscribe to track BDX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Becton Dickinson EVP Sells $123k in Stock Under 10b5-1 Plan
Company: BECTON DICKINSON & CO (BDX) Form: 4 | Filed: 2025-12-17 Significance: Low
Insider: Garrison Michael David Title: EVP & Pres Med.Essntl&BioPharm | Relationship: Officer
Transaction: • Type: Sale • Shares: 629 • Price: $196.03 • Value: $123,303 • Owned After: 13,105
Key Insight: This is a minor, pre-scheduled sale under a 10b5-1 plan, representing a negligible fraction of the company's market cap and the insider's holdings. It carries little to no informational value.
Market Context: For a large-cap company like BDX ($55B market cap), this transaction size is immaterial.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: BECTON DICKINSON & CO (BDX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive sold a small number of shares under a pre-arranged 10b5-1 trading plan, indicating the transaction is likely for personal financial planning and not a reflection of a change in outlook for the company.
- Market Impact: Negligible. The transaction is too small to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | BECTON DICKINSON & CO |
| Ticker Symbol | BDX |
| CIK | 0000010795 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Garrison Michael David |
| CIK | 0001944816 |
| Title/Position | EVP & Pres Med.Essntl&BioPharm |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-17 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 629 |
| Price Per Share | $196.03 |
| Total Value | $123,302.87 |
| Shares Owned After | 13,105 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $123,302.87 |
| % of Market Cap | 0.00022% |
| Shares Transacted | 629 |
| % of Shares Outstanding | 0.00022% |
| Post-Transaction Ownership | 13,105 shares (0.0046% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Becton Dickinson is a large-cap company with a market capitalization of $55.33 billion. A transaction of ~$123k is financially insignificant in this context.
- Ownership Concentration: The insider's post-transaction ownership of 13,105 shares represents a very small fraction (0.0046%) of the total shares outstanding.
- Transaction Significance: The sale represents less than 5% of the insider's direct holdings and is a minuscule percentage of both market cap and shares outstanding. Its significance is therefore rated as Low.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is extremely small relative to the company's size and was executed under a Rule 10b5-1 plan, which severs the link between the sale and any immediate insider sentiment. It is considered a routine, non-informational event.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is too small to be noticeable against the stock's average daily trading volume.
- Sentiment Indicator: Neutral. Pre-planned sales by executives are common for liquidity and tax planning and do not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing explicitly states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025. This indicates the sale was pre-scheduled and not based on any new, non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
